Marc Joan van de Vijver

Research output

Research output per year 1972 1999 2000 2006 2007 2008 2009 2010 2011 2012 2014 2016 2019 2020 2022 2023

• 255 Article
• 24 Review article
• 23 Comment/Letter to the editor
• 2 Chapter
• 3 More
  • 2 Editorial
  • 1 Erratum/Corrigendum

Research output per year

Research output per year

Search results

• 2023

  Author Correction: Pan-cancer analysis of whole genomes (Nature, (2020), 578, 7793, (82-93), 10.1038/s41586-020-1969-6)

  The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, 16 Feb 2023, In: NATURE. 614, 7948, p. E39

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  1 Citation (Scopus)

• Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x)

  PCAWG Consortium, 1 Jun 2023, In: Nature Genetics. 55, 6, p. 1078 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Author Correction: The landscape of viral associations in human cancers (Nature Genetics, (2020), 52, 3, (320-330), 10.1038/s41588-019-0558-9)

  PCAWG Pathogens & PCAWG Consortium, 1 Jun 2023, In: Nature Genetics. 55, 6, p. 1077 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition (Nature Genetics, (2020), 52, 3, (306-319), 10.1038/s41588-019-0562-0)

  PCAWG Structural Variation Working Group & PCAWG Consortium, 1 Jun 2023, In: Nature Genetics. 55, 6, p. 1080 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  1 Citation (Scopus)

• Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing (Nature Genetics, (2020), 52, 3, (331-341), 10.1038/s41588-019-0576-7)

  PCAWG Consortium & PCAWG Structural Variation Working Group, 1 Jun 2023, In: Nature Genetics. 55, 6, p. 1076 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (Nature Genetics, (2020), 52, 3, (294-305), 10.1038/s41588-019-0564-y)

  PCAWG Consortium & PCAWG Structural Variation Working Group, 1 Jun 2023, In: Nature Genetics. 55, 6, p. 1079 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Detecting KRAS mutations in pancreatic cystic neoplasms: droplet digital PCR versus targeted next-generation sequencing

  van Huijgevoort, N. C. M., Halfwerk, H. B. G., Lekkerkerker, S. J., Reinten, R. J., Ramp, F., Fockens, P., Besselink, M. G., Busch, O. R., van Noesel, C. J. M., van de Vijver, M. J., Verheij, J., van Hooft, J. E. & Dijk, F., 1 Jan 2023, In: HPB: The official journal of the International Hepato Pancreato Biliary Association. 25, 1, p. 155-159 5 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
• 2022

  Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours (Nature Communications, (2020), 11, 1, (737), 10.1038/s41467-019-14052-x)

  PCAWG Consortium, 1 Dec 2022, In: Nature communications. 13, 1, 7569.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  1 Citation (Scopus)

• Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns (Nature Communications, (2020), 11, 1, (728), 10.1038/s41467-019-13825-8)

  PCAWG Tumor Subtypes and Clinical Translation Working Group & PCAWG Consortium, 1 Dec 2022, In: Nature communications. 13, 1, 7573.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations (Nature Communications, (2020), 11, 1, (736), 10.1038/s41467-019-13885-w)

  PCAWG Structural Variation Working Group, PCAWG Consortium & PCAWG Transcriptome Working Group, 1 Dec 2022, In: Nature communications. 13, 1, 7572.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Author Correction: Inferring structural variant cancer cell fraction (Nature Communications, (2020), 11, 1, (730), 10.1038/s41467-020-14351-8)

  PCAWG Evolution and Heterogeneity Working Group & PCAWG Consortium, 1 Dec 2022, In: Nature communications. 13, 1, 7568.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer (Nature Communications, (2020), 11, 1, (733), 10.1038/s41467-019-13824-9)

  PCAWG-Structural Variation Working Group & PCAWG Consortium, 1 Dec 2022, In: Nature communications. 13, 1, 7574.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig (Nature Communications, (2020), 11, 1, (731), 10.1038/s41467-020-14352-7)

  PCAWG Evolution and Heterogeneity Working Group & PCAWG Consortium, 1 Dec 2022, In: Nature communications. 13, 1, 7567.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes (Nature Communications, (2020), 11, 1, (729), 10.1038/s41467-020-14367-0)

  PCAWG Drivers and Functional Interpretation Working Group & PCAWG Consortium, 1 Dec 2022, In: Nature communications. 13, 1, 7566.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
• 2021

  Corrigendum to “A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients” [Radiother Oncol 156 (2021) 127-135] (Radiotherapy and Oncology (2021) 156(127-135) (S0167814020311956), (10.1016/j.radonc.2020.11.025))

  Young Boost Trial research group, Oct 2021, In: Radiotherapy and oncology. 163, p. 244 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
• 2020

  Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (Nature Communications, (2020), 11, 1, (4748), 10.1038/s41467-020-18151-y)

  PCAWG novel somatic mutation calling methods working group, PCAWG Consortium & MC3 Working Group, 1 Dec 2020, In: Nature communications. 11, 1, 6232.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
• 2015

  Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach (vol 152, pg 247, 2015)

  Dekker, T. J. A., ter Borg, S., Meijer, S. L., Wesseling, J., Boers, J. E., Schuuring, E., Bart, J., van Gorp, J., Bult, P., Riemersma, S. A., van Deurzen, C. H. M., Sleddens, H. F. B. M., Mesker, W. E., Kroep, J. R., Smit, V. T. H. B. M. & van de Vijver, M. J., 2015, In: Breast cancer research and treatment. 152, 2, p. 253

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  3 Citations (Scopus)
• 2010

  HER-2 amplification is highly homogenous in gastric cancer

  Bilous, M., Osamura, R. Y., Rüschoff, J., van de Vijver, M., Hanna, W., Penault-Llorca, F. & Roche, P., 2010, In: Human Pathology. 41, 2, p. 304-5; author reply 305-6

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  33 Citations (Scopus)
• 2009

  Postmastectomy radiotherapy: Will the selective use of postmastectomy radiotherapy study end the debate?

  Russell, N. S., Kunkler, I. H., van Tienhoven, G., Canney, P. A., Thomas, J., Bartlett, J., van de Vijver, M. J., Belkacemi, Y., Yarnold, J. R. & Barrett-Lee, P. J., 2009, In: Journal of clinical oncology. 27, 6, p. 996-997

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  15 Citations (Scopus)
• 2008

  ESR1 gene amplification in breast cancer: a common phenomenon?

  Horlings, H. M., Bergamaschi, A., Nordgard, S. H., Kim, Y. H., Han, W., Noh, D-Y., Salari, K., Joosse, S. A., Reyal, F., Lingjaerde, O. C., Kristensen, V. N., Børresen-Dale, A-L., Pollack, J. & van de Vijver, M. J., 2008, In: Nature Genetics. 40, 7, p. 807-8; author reply 810-2

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  48 Citations (Scopus)
• 2007

  Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response

  Kreike, B. & van de Vijver, M. J., 2007, In: Breast Cancer Research. 9, 6, p. 405

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  6 Citations (Scopus)
• 2003

  Expression profiling predicts outcome in breast cancer

  van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Bernards, R. & Friend, S. H., 2003, In: Breast Cancer Research. 5, 1, p. 57-58

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  155 Citations (Scopus)
• 1987

  Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene

  van de Vijver, M., van de Bersselaar, R., Devilee, P., Cornelisse, C., Peterse, J. & Nusse, R., 1987, In: Molecular and Cellular Biology. 7, 5, p. 2019-2023

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  323 Citations (Scopus)